Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ex-vivo Modulatory Effect of Biological Drugs for Inflammatory Bowel Disease on the Mucosa and on Peripheral Blood Mononuclear Cells

NCT03043677 is registered in ClinicalTrials.gov with Fundación de Investigación Biomédica - Hospital Universitario de La Princesa as lead sponsor.

NCT NCT03043677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03043677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ex-vivo Modulatory Effect of Biological Drugs for Inflammatory Bowel Disease on the Mucosa and on Peripheral Blood Mononuclear Cells
Lead sponsor
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Phase
Observational
Overall status
Completed
Start date
April 1, 2016
Completion date
May 30, 2018
Enrollment
45 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel disease